K. D. Danenberg

2.2k total citations
41 papers, 1.8k citations indexed

About

K. D. Danenberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, K. D. Danenberg has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in K. D. Danenberg's work include Colorectal Cancer Treatments and Studies (17 papers), Cancer Genomics and Diagnostics (10 papers) and Lung Cancer Treatments and Mutations (8 papers). K. D. Danenberg is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Cancer Genomics and Diagnostics (10 papers) and Lung Cancer Treatments and Mutations (8 papers). K. D. Danenberg collaborates with scholars based in United States, Germany and Japan. K. D. Danenberg's co-authors include P. V. Danenberg, Leonard B. Saltz, Cindy A. Eads, Peter W. Laird, Kazuyuki Kawakami, Heinz‐Josef Lenz, Peter V. Danenberg, Jan Brabender, Stephen Yang and Cármen Jerónimo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

K. D. Danenberg

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. D. Danenberg United States	15	1.1k	825	555	422	262	41	1.8k
Tae-You Kim South Korea	24	678 0.6×	689 0.8×	420 0.8×	277 0.7×	299 1.1×	48	1.5k
Renata A. Coudry Brazil	20	587 0.6×	624 0.8×	557 1.0×	438 1.0×	169 0.6×	37	1.4k
Anna Maria Rachiglio Italy	20	575 0.5×	819 1.0×	544 1.0×	607 1.4×	309 1.2×	43	1.5k
Yoshio Tomizawa Japan	24	1.1k 1.0×	1.1k 1.3×	991 1.8×	383 0.9×	140 0.5×	72	2.2k
Angelica Fasolo Italy	18	674 0.6×	856 1.0×	390 0.7×	284 0.7×	191 0.7×	43	1.5k
Haruhiro Yukiue Japan	29	839 0.8×	812 1.0×	1.1k 1.9×	352 0.8×	111 0.4×	71	2.0k
Cheng‐long Huang Japan	26	1.3k 1.2×	973 1.2×	673 1.2×	478 1.1×	129 0.5×	68	2.3k
Rosa Caputo Italy	20	1.0k 1.0×	1.3k 1.6×	906 1.6×	355 0.8×	163 0.6×	21	2.3k
S. Vignati Italy	15	879 0.8×	793 1.0×	569 1.0×	388 0.9×	91 0.3×	22	1.6k
Omar Kabbarah United States	18	620 0.6×	797 1.0×	301 0.5×	349 0.8×	409 1.6×	42	1.5k

Countries citing papers authored by K. D. Danenberg

Since Specialization

Citations

This map shows the geographic impact of K. D. Danenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. D. Danenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. D. Danenberg more than expected).

Fields of papers citing papers by K. D. Danenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. D. Danenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. D. Danenberg. The network helps show where K. D. Danenberg may publish in the future.

Co-authorship network of co-authors of K. D. Danenberg

This figure shows the co-authorship network connecting the top 25 collaborators of K. D. Danenberg. A scholar is included among the top collaborators of K. D. Danenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. D. Danenberg. K. D. Danenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maus, Martin, Peter Grimminger, Philip C. Mack, et al.. (2013). KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung Cancer. 83(2). 163–167. 31 indexed citations

Xie, Yang, Guanghua Xiao, Kevin R. Coombes, et al.. (2011). Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients. Clinical Cancer Research. 17(17). 5705–5714. 130 indexed citations

Iqbal, Syma, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, et al.. (2011). Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer. Annals of Oncology. 22(12). 2610–2615. 123 indexed citations

Lara, P.C., et al.. (2011). BRCA1 mRNA expression patterns in a large lung cancer cohort.. Journal of Clinical Oncology. 29(15_suppl). 7056–7056. 1 indexed citations

Wilson, Peter M., Anthony B. El-Khoueiry, Syma Iqbal, et al.. (2010). A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy. Cancer Chemotherapy and Pharmacology. 65(5). 979–988. 49 indexed citations

Danenberg, K. D., et al.. (2010). KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy.. Journal of Clinical Oncology. 28(15_suppl). 10529–10529. 9 indexed citations

Vallböhmer, Daniel, Dongyun Yang, K. D. Danenberg, et al.. (2010). Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in advanced rectal cancer.. Journal of Clinical Oncology. 28(15_suppl). 3563–3563. 2 indexed citations

Press, Michael F., Richard S. Finn, David Cameron, et al.. (2008). HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer. Clinical Cancer Research. 14(23). 7861–7870. 134 indexed citations

Somlo, George, P Chu, Paul Frankel, et al.. (2008). Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. Annals of Oncology. 19(11). 1853–1859. 23 indexed citations

10.

Collisson, Eric A., Dibash Kumar Das, Andreas-Claudius Hoffmann, et al.. (2008). Use of whole genome expression analysis of pancreatic adenocarcinoma to predict prognosis after OXi4503 surgery. Journal of Clinical Oncology. 26(15_suppl). 4503–4503. 5 indexed citations

11.

Collisson, Eric A., Andreas-Claudius Hoffmann, Grace Kim, et al.. (2008). Different pancreatic cancer genomic risk prediction models derived from microdissected and non-microdissected paraffin-embedded tissue. Journal of Clinical Oncology. 26(15_suppl). 4622–4622. 2 indexed citations

12.

Azuma, Mizutomo, Dongliang Yang, Ellen Hollywood, et al.. (2007). Molecular markers associated with response and clinical outcome to cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer (BOND2). Journal of Clinical Oncology. 25(18_suppl). 4113–4113. 2 indexed citations

13.

Ceppi, Paolo, Marco Volante, Silvia Novello, et al.. (2006). ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Annals of Oncology. 17(12). 1818–1825. 270 indexed citations

14.

Haile, Robert W., Victoria K. Cortessis, Jesse Lin, et al.. (2005). A Molecular/Epidemiologic Analysis of Expression of Cyclooxygenases 1 and 2,Use of Nonsteroidal Antiinflammatory Drugs, and Risk of Colorectal Adenoma. Clinical Colorectal Cancer. 4(6). 390–395. 6 indexed citations

15.

Danenberg, K. D., Jan Brabender, Stephan Schneider, et al.. (2004). Gender differences in the predictive power of prognostic factors in NSCLC. Journal of Clinical Oncology. 22(14_suppl). 7008–7008. 5 indexed citations

16.

Shimizu, Daisuke, Jeff Peters, Sven Schneider, et al.. (2004). Cyclooxygenase-2 (COX-2) mediated anti-apoptosis may occur via Bcl-2 in the progression of Barrett's esophagus to adenocarcinoma. Journal of Clinical Oncology. 22(14_suppl). 9529–9529. 3 indexed citations

17.

Formenti, Silvia C., Darcy Spicer, Kristin A. Skinner, et al.. (2002). Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. International Journal of Radiation Oncology*Biology*Physics. 52(2). 397–405. 32 indexed citations

18.

Kan‐Mitchell, June, Peter E. Liggett, C. R. Taylor, et al.. (1993). Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.. PubMed. 34(12). 3366–75. 14 indexed citations

19.

Volkenandt, Matthias, Adam P. Dicker, Debabrata Banerjee, et al.. (1992). Quantitation of Gene Copy Number and mRNA Using the Polymerase Chain Reaction. Experimental Biology and Medicine. 200(1). 1–6. 33 indexed citations

20.

Torigoe, Soichiro, et al.. (1992). p53 gene mutation in primary human renal cell carcinoma.. PubMed. 4(11-12). 467–72. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact